Home4559 • TYO
add
Zeria Pharmaceutical Co Ltd
Previous close
¥2,270.00
Day range
¥2,280.00 - ¥2,324.00
Year range
¥1,880.00 - ¥2,469.00
Market cap
122.76B JPY
Avg Volume
53.31K
P/E ratio
11.28
Dividend yield
1.90%
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
(JPY) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 21.46B | 17.21% |
Operating expense | 12.04B | 11.89% |
Net income | 4.21B | 44.49% |
Net profit margin | 19.63 | 23.23% |
Earnings per share | — | — |
EBITDA | 5.83B | 29.30% |
Effective tax rate | 22.38% | — |
Balance Sheet
Total assets
Total liabilities
(JPY) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.90B | 17.85% |
Total assets | 152.12B | 9.38% |
Total liabilities | 69.94B | -2.51% |
Total equity | 82.18B | — |
Shares outstanding | 44.08M | — |
Price to book | 1.22 | — |
Return on assets | 6.51% | — |
Return on capital | 7.80% | — |
Cash Flow
Net change in cash
(JPY) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 4.21B | 44.49% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
CEO
Founded
Dec 22, 1955
Website
Employees
1,777